
### [NCIT:C8986](http://purl.obolibrary.org/obo/NCIT_C8986)
**Label:** Papillary Adenofibroma

**Subclasses:** [NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma), [NCIT:C40028](http://purl.obolibrary.org/obo/NCIT_C40028) (Borderline Ovarian Serous Adenofibroma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell) 52.94%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 52.94%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 38.30%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36834](http://purl.obolibrary.org/obo/NCIT_C36834) (Tingible Body Macrophage))) 38.30%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36833](http://purl.obolibrary.org/obo/NCIT_C36833) (Lipid-Laden Macrophage))) 38.30%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36824](http://purl.obolibrary.org/obo/NCIT_C36824) (Malignant Epithelial Giant Cell))) 38.30%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C36821](http://purl.obolibrary.org/obo/NCIT_C36821) (Malignant Neuroendocrine Large Cell))) 38.30%


